RecruitingNCT06775535

Neuronal Activation Accuracy in Closed-loop Spinal Cord Stimulation

Assessment of Neuronal Activation Accuracy and Stimulation Sensation in Patients with Closed-loop Spinal Cord Stimulation (CL-SCS) Therapy

Sponsor

Karel Hanssens

Enrollment

12 participants

Start Date

Aug 2, 2023

Study Type

OBSERVATIONAL

Conditions

Chronic Pain Neuropathic Pain Persistent Spinal Pain Syndrome Type 2

Summary

Observational, prospective, single-center to assess neuronal activation accuracy and stimulation sensation in patients with closed-loop spinal cord stimulation therapy.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called ECAP-controlled, closed-loop SCS for people with chronic pain, neuropathic pain, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEECAP-controlled, closed-loop SCS

Spinal cord stimulation that measures and records evoked compound action potentials (ECAPs) and automatically adjusts the stimulation current to maintain a consistent ECAP amplitude